Asia Pacific Cardiac Microcatheter Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028

Analysis- by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

No. of Pages: 116
Report Code: BMIRE00028749
Category: Life Sciences
Asia Pacific Cardiac Microcatheter Market
Buy Now

The Asia Pacific cardiac microcatheter market is expected to grow from US$ 80.47 million in 2023 to US$ 114.76 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2023 to 2028.   

Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter Fuel Asia Pacific Cardiac Microcatheter Market

As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in complex vascular anatomies. Manufacturers across the world are investing in research and development of advanced technologies, which has led to the development of new and advanced products, along with a surge in product approvals. A few product approvals and developments are listed below ; In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions. In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease. In May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.

Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheter is expected to fuel the cardiac microcatheter market growth during the forecast period.

Asia Pacific Cardiac Microcatheter Market Overview

The Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region occupies a significant position in the Asia Pacific cardiac microcatheter market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures. 

 Asia Pacific Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)

 Asia Pacific Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)Asia Pacific Cardiac Microcatheter Market Segmentation

The Asia Pacific cardiac microcatheter market is segmented into indication, end user, and country.

Based on indication, the Asia Pacific cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the Asia Pacific cardiac microcatheter market in 2023.

Based on end user, the Asia Pacific cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the Asia Pacific cardiac microcatheter market in 2023.

Based on country, the Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific cardiac microcatheter market in 2023.   

Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; OrbusNeich Medical Group Holdings Ltd; Teleflex Inc; Terumo Corp; and Tokai Medical Products Inc are the leading companies operating in the Asia Pacific cardiac microcatheter market.    

Asia Pacific Cardiac Microcatheter Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Asia Pacific Cardiac Microcatheter Market Segmentation Analysis

Asia Pacific Cardiac Microcatheter Market Report Highlights

Asia Pacific Cardiac Microcatheter Report Scope

Report Attribute Details
Market size in 2023 US$ 80.47 Million
Market Size by 2028 US$ 114.76 Million
CAGR (2023 - 2028) 7.4%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By Indication
  • General Peripheral Vascular and Coronary
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Boston Scientific Corp
  • Integer Holdings Corp
  • Medtronic Plc
  • Merit Medical Systems Inc
  • Nipro Corp
  • OrbusNeich Medical Group Holdings Ltd
  • Teleflex Inc
  • Terumo Corp
  • Tokai Medical Products Inc
Get more information on this report

Asia Pacific Cardiac Microcatheter Market Country and Regional Insights

asia-pacific-cardiac-microcatheter-market
Get more information on this report

The List of Companies - Asia Pacific Cardiac Microcatheter Market

  1. Boston Scientific Corp
  2. Integer Holdings Corp
  3. Medtronic Plc
  4. Merit Medical Systems Inc
  5. Nipro Corp
  6. OrbusNeich Medical Group Holdings Ltd
  7. Teleflex Inc
  8. Terumo Corp
  9. Tokai Medical Products Inc
Frequently Asked Questions
How big is the Asia Pacific Cardiac Microcatheter Market?

The Asia Pacific Cardiac Microcatheter Market is valued at US$ 80.47 Million in 2023, it is projected to reach US$ 114.76 Million by 2028.

What is the CAGR for Asia Pacific Cardiac Microcatheter Market by (2023 - 2028)?

As per our report Asia Pacific Cardiac Microcatheter Market, the market size is valued at US$ 80.47 Million in 2023, projecting it to reach US$ 114.76 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.

What segments are covered in this report?

The Asia Pacific Cardiac Microcatheter Market report typically cover these key segments-

  • Indication (General Peripheral Vascular and Coronary)
  • End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)

What is the historic period, base year, and forecast period taken for Asia Pacific Cardiac Microcatheter Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cardiac Microcatheter Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Asia Pacific Cardiac Microcatheter Market?

    The Asia Pacific Cardiac Microcatheter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Boston Scientific Corp
  • Integer Holdings Corp
  • Medtronic Plc
  • Merit Medical Systems Inc
  • Nipro Corp
  • OrbusNeich Medical Group Holdings Ltd
  • Teleflex Inc
  • Terumo Corp
  • Tokai Medical Products Inc
  • Who should buy this report?

    The Asia Pacific Cardiac Microcatheter Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Cardiac Microcatheter Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)